Markets
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6271.0000
-26.50
(
-0.42
%)
NSE
Feb 20, 2026
11:24 AM
26.56% Gain from 52W Low
Volume:
62,938
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
25 Mar 2025
6271.00
-0.42%
DIVI' S LAB
Hold:
Divi's Laboratories Ltd.
by
Geojit BNP Paribas
Target: 6375 | Target met
Target
Geojit BNP Paribas
Number of FII/FPI investors decreased from 897 to 868 in Dec 2025 qtr
More from Divi's Laboratories Ltd.
Recommended
Market trades higher, Texmaco Rail forms a JV with RVNL to expand EPC project footprint
Trendlyne Marketwatch |
20 Feb 2026, 11:16AM
3 picks: Capex plans and big dreams for three electronics players
The Baseline |
19 Feb 2026, 12:25PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022